Ionizable Polyester Polyplexes for Lung-Selective Macrophage Transfection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering nucleic acids to immune cells, particularly macrophages, face challenges such as enzymatic degradation and low transfection efficiency due to the low proliferative nature of primary cells.
Innovation Solution
A one-pot synthesis of hydrophobic ionizable polyesters is developed as a single-component nucleic acid delivery platform, which demonstrates high serum and enzymatic stability and efficient transfection of innate immune cells, including lung-selective mRNA transfection in vivo.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If viral vectors are used for nucleic acid delivery, then transfection efficiency is improved, but safety concerns including mutagenesis, immunogenicity, and cytotoxicity arise
Solution Approach 1:
The patent employs non-viral polymer-based delivery systems (such as polyethylenimine and other cationic polymers) that are safer, non-pathogenic alternatives to viral vectors. These polymers can be easily synthesized, are non-immunogenic, and do not carry the risks of mutagenesis or cytotoxicity associated with viral vectors, while still achieving effective nucleic acid delivery to immune cells
Solution Approach 2:
The patent modifies the chemical and physical parameters of the delivery system by using ionizable polyesters with specific molecular weights, charges, and degradation rates. These parameter adjustments enable the system to achieve viral-like transfection efficiency while maintaining the safety profile of non-viral materials, resolving the contradiction between efficiency and safety
2Object-affected harmful factors
If non-viral gene delivery methods are used, then safety concerns are reduced, but transfection efficiency to primary immune cells remains marginal
Solution Approach 1:
The patent introduces cell-type specific targeting moieties (such as antibodies, peptides, or aptamers) conjugated to the polymer surface that selectively bind to markers on primary immune cells. This local quality enhancement enables the non-viral system to achieve high transfection efficiency specifically in target immune cells while maintaining overall safety profile
Solution Approach 2:
The patent creates composite delivery systems combining cationic polymers with lipid nanoparticles, targeting moieties, and surface coatings. These composite structures enhance the ability of non-viral materials to penetrate cell membranes and deliver nucleic acids to primary immune cells, achieving efficiency comparable to viral vectors without the associated risks
3Productivity
If lipid nanoparticles are used for nucleic acid delivery, then delivery efficacy is improved, but synthesis complexity and cost-effectiveness worsen
Solution Approach 1:
The patent extracts and eliminates the complex lipid component from the delivery system, using solely polymer-based carriers. This simplification reduces synthesis steps, lowers manufacturing costs, and enables scalable production while maintaining delivery efficacy through optimized polymer properties such as molecular weight, charge density, and degradation characteristics
Solution Approach 2:
The patent employs readily available, easily synthesized polymers (such as polyethylenimine, polylysine, and custom ionizable polyesters) that can be produced through simple, cost-effective chemical synthesis. These polymer materials are inexpensive, can be scaled industrially, and avoid the complex purification and characterization requirements of lipid nanoparticles
4Productivity
If cationic polymers are used for nucleic acid delivery, then nucleic acid complexation is improved, but toxicity increases
Solution Approach 1:
The patent employs ionizable polyesters that dynamically change their charge state based on pH. At physiological pH, the polymers are neutral or weakly cationic, reducing toxicity. Upon uptake by cells or in the endosomal environment, the polymers become protonated and cationic, enabling efficient nucleic acid complexation and endosomal escape. This dynamic charge transition resolves the contradiction between complexation efficiency and toxicity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The ionizable polyesters achieve over 23-fold lung-selective protein expression and efficient transfection of lung alveolar macrophages and dendritic cells without detectable organ toxicity or systemic inflammation, showcasing a stable and effective non-viral delivery platform.
Implementation Method 1
The field of the invention relates generally to compositions and methods for delivering nucleic acids to cells... ionizable polyesters... single-component nucleic acid delivery platform
Data Source
AI summary
The present invention provides ionizable polyesters, compositions comprising ionizable polyester polyplexes, and methods of delivering nucleic acids to cells comprising administering the polyplexes to subjects.